Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics had revenue of $1.22M in the quarter ending March 31, 2025, a decrease of -76.83%. This brings the company's revenue in the last twelve months to $3.64M, down -67.87% year-over-year. In the year 2024, Bolt Biotherapeutics had annual revenue of $7.69M, down -2.36%.

• Revenue (ttm): $3.64M
• Revenue Growth: -67.87%
• P/S Ratio: 3.08
• Revenue / Employee: $69,962
• Employees: 52
• Market Cap: 11.23M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.69M	-186.00K	-2.36%
Dec 31, 2023	7.88M	2.15M	37.48%
Dec 31, 2022	5.73M	4.47M	354.68%
Dec 31, 2021	1.26M	1.03M	445.45%
Dec 31, 2020	231.00K	16.00K	7.44%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.